Indefinite Delivery Contract SPE2DR25D2917

Award Date 9/1/25
Last Date to Order 12/31/36
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The Indefinite Delivery Contract (IDC) SPE2DR25D6035 was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $999,999,999, is a single-award IDC with a period of performance through December 31, 2036. The purpose of this IDC is to establish a Pharmaceutical Prime Vendor Global Program to provide worldwide pharmaceutical support, including...
The Indefinite Delivery Contract (IDC) SPE2DR25D2007 is a single-award contract valued at $999,999,999 awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp. The contract has an ultimate completion date of December 31, 2036 and serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This IDC is part of the DLA's Pharmaceutical Prime Vendor...
The Indefinite Delivery Contract (IDC) SPE2DR25D3941, awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, is a $999,999,999 contract to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic...
The Indefinite Delivery Contract (IDC) SPE2DR25D7910 was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $999,999,999, has a period of performance through December 2026 and is intended to provide worldwide pharmaceutical support to various Department of Defense (DoD) customers, including the Defense Health Agency, the U.S. Coast Guard, and...
The Indefinite Delivery Contract (IDC) SPE2DX25D5000 was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain, a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a total ceiling value of $999,999,999 and runs through March 2035. The purpose of this IDC is to establish Pharmaceutical Prime Vendor Global Program Generation V contracts to provide worldwide pharmaceutical support,...
The Indefinite Delivery Contract (IDC) SPE2DR25D2104 was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This $999,999,999 single-award IDC, running through December 2036, is part of the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) procurement. It aims to establish prime vendor contracts to provide worldwide pharmaceutical support,...
The Indefinite Delivery Contract (IDC) SPE2DR25D2018 is a $999,999,999 single-award contract issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract's purpose is to provide a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to support military healthcare programs globally. This...
The indefinite delivery contract (IDC) SPE2DR25D1007 was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide a comprehensive range of pharmaceutical products and medical supplies in support of military healthcare programs globally. The $9,999,999,999 single-award IDC has a 30-month base period with three 30-month option periods, totaling an estimated $30.3 billion in value. The contract...
The Indefinite Delivery Contract (IDC) SPE2DR25D3016 was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $999,999,999 contract covers a wide range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic areas. The contract serves to provide...
The Indefinite Delivery Contract (IDC) SPE2DR25D1002, awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, is a single-award contract valued at $9,999,999,999 running through December 31, 2036. This IDC serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, syringes,...

The Indefinite Delivery Contract (IDC) SPE2DR25D2917 is a $999,999,999 single-award contract awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a base period of 30 months and three 30-month option periods, running through December 2036.

The purpose of this IDC is to establish Pharmaceutical Prime Vendor (PPV) Global Program Generation V contracts to provide worldwide pharmaceutical support to various DoD customers, including the Defense Health Agency, U.S. Coast Guard, and U.S. Naval Fleet. The contract covers a comprehensive range of pharmaceutical products such as brand-name and generic drugs, specialty medications, vaccines, syringes, vials, and test kits across multiple therapeutic areas. The contractor will be responsible for furnishing these medical commodities in support of normal day-to-day operations, as well as planned and unplanned contingencies, for CONUS and OCONUS locations. This is an unrestricted, fully competitive acquisition, with awards made on a regional basis to at least three different contractors.

Generated 6/6/25, 9:58 AM